As of 2025-12-26, the Fair Value of Maravai LifeSciences Holdings Inc (MRVI) is -11.85 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.30 USD, the upside of Maravai LifeSciences Holdings Inc is -459.18%.
With the market price of 3.30 USD and our fair value calculation, Maravai LifeSciences Holdings Inc (MRVI) is not a good investment. Investing in MRVI stocks now will result in a potential loss of 459.18%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 92.20 | 182.00 | 220.20 | -119.03 | -144.85 | 46.10 |
| YoY growth | 3,392.86% | 97.40% | 20.99% | -154.05% | -21.69% | 667.10% |
| Market Cap (mil) | 843.84 |
| P/E | |
| Forward P/E |
| EPS | -0.47 |
| Avg earnings growth rate | 667.10% |
| TTM earnings | -121.24 |